NDC product
childrens allergy relief
NDC 51316-818 · CVS WOONSOCKET PRESCRIPTION CENTER, INCORPORATED
Key facts
| Product NDC | 51316-818 |
|---|---|
| Proprietary name | childrens allergy relief |
| Nonproprietary name | Fluticasone Propionate |
| Substances | FLUTICASONE PROPIONATE |
| Dosage form | SPRAY, METERED |
| Route | NASAL |
| Labeler | CVS WOONSOCKET PRESCRIPTION CENTER, INCORPORATED |
| Product type | HUMAN OTC DRUG |
| Marketing category | ANDA |
| Application number | ANDA207957 |
| Pharmacologic classes | Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC] |
| Marketing start | Apr 13, 2026 |
| Listing certified through | Dec 31, 2027 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: